Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Atrion Corporation

Market Cap 81Cr 71Cr 65Cr 61Cr 114.76Cr 7.64TCr 115.45Cr 775.42Cr 300.52Cr 3.76TCr 303.84Cr 297.32Cr 13TCr P/E 2022
28.6x
P/E 2023 34.4x
Enterprise Value 80Cr 70Cr 65Cr 61Cr 113.9Cr 7.58TCr 114.59Cr 769.66Cr 298.29Cr 3.73TCr 301.58Cr 295.11Cr 13TCr EV / Sales 2022
5.27x
EV / Sales 2023 3.9x
Free-Float
50.88%
Yield 2022
1.47%
Yield 2023 2.3%
3 years 274.98
Extreme 274.98
602.59
5 years 274.98
Extreme 274.98
805.62
10 years 274.98
Extreme 274.98
948.03
Manager TitleAgeSince
Corporate Secretary 53 21/08/2024
Director TitleAgeSince
Director/Board Member 53 21/08/2024
Date Insider Type Main position Quantity % Market Cap.
21/24/21Issuer sale

Director

1,51,205 8.5914%
21/24/21Issuer sale

Chief Financial Officer

2,223 0.1263%
21/24/21Issuer sale

Chairman

1,50,927 8.5756%
Change 5-day change 1-year change 3-year change Capi.($)
+0.06%-.--%-.--%-19.71% 81Cr
-0.10%+0.26%-33.52%-17.14% 15TCr
+1.54%-1.07%-8.11%-10.79% 10TCr
-4.45%+3.12%+61.36%+57.49% 5.65TCr
-1.90%-3.49%-7.43%+47.34% 5.29TCr
+1.67%-1.55%-14.51%-43.86% 3.97TCr
-1.32%-1.83% - - 3.04TCr
+1.74%-3.85%-9.41%-44.24% 2.8TCr
+1.35%-0.26%+51.96%-10.42% 2.32TCr
-1.53%+1.14%-15.21%-5.72% 2.03TCr
Average -0.29%-1.17%+2.79%-5.23% 5.08TCr
Weighted average by Cap. -0.27%-1.24%-5.99%-2.80%

Financials

2022 2023
Net sales 18Cr 16Cr 15Cr 14Cr 26Cr 1.73TCr 26Cr 175.79Cr 68Cr 852.28Cr 69Cr 67Cr 2.96TCr 17Cr 15Cr 14Cr 13Cr 24Cr 1.6TCr 24Cr 162.21Cr 63Cr 786.42Cr 64Cr 62Cr 2.73TCr
Net income 3.5Cr 3.05Cr 2.83Cr 2.65Cr 4.96Cr 330.33Cr 4.99Cr 34Cr 13Cr 162.59Cr 13Cr 13Cr 564.56Cr 1.94Cr 1.69Cr 1.57Cr 1.47Cr 2.75Cr 183.16Cr 2.77Cr 19Cr 7.21Cr 90Cr 7.29Cr 7.13Cr 313.04Cr
Net Debt -2.52Cr -2.2Cr -2.04Cr -1.91Cr -3.57Cr -237.89Cr -3.6Cr -24Cr -9.36Cr -117.09Cr -9.46Cr -9.26Cr -406.57Cr -60.16L -52.45L -48.58L -45.48L -85.29L -57Cr -85.81L -5.76Cr -2.23Cr -28Cr -2.26Cr -2.21Cr -97Cr
Logo Atrion Corporation
Atrion Corporation develops and manufactures products, primarily for medical applications. The Company's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. It has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The Company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.
Employees
712
  1. Stock Market
  2. Stocks
  3. ATRI Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!